← Back
Aligos Therapeutics
ALGS · listed on Nasdaq · worth $40.97 million
$4.65
+0.10% today
No insider trades reported for Aligos Therapeutics yet.
No insider trades or company news in this range.
The shares anyone can buy and sell, leaving out those held by insiders and big long-term owners.
3.6M shares
68% of all shares
Shares borrowed and sold by investors who expect the price to drop.
Big investors
People and funds that reported owning 5% or more of Aligos Therapeutics, newest first.
Filed by someone who owns 5% or more and may try to influence how the company is run.Blatt Lawrence5.6%Jun 24
All reports
Every insider trade and SEC report we hold for Aligos Therapeutics.
Newest first
No insider trades reported for ALGS yet.
Analysts, earnings and news
Analysts' price target
$52.38 average
8 analysts
Analysts' opinions, which tend to run optimistic. Not our forecast or advice.
Profit vs what was expected
3 of 4 quarters above
Q2 '26−$0.14 a share+$1.10
Q1 '26−$2.21 a share+$0.04
Q4 '25−$1.91 a share+$0.58
Q3 '25−$3.04 a share−$1.03